Literature DB >> 18457371

Production, characterization of a monoclonal antibody against aristolochic acid-II and development of its assay system.

Min Tian1, Hiroyuki Tanaka, Ming-Ying Shang, Seiko Karashima, Zhi Chao, Xuan Wang, Shao-Qing Cai, Yukihiro Shoyama.   

Abstract

Aristolochic acid-II (AA-II) conjugated with bovine serum albumin (BSA) was used as an antigen for immunizing BALB/c mice. Isolated splenocytes from the immunized mice were fused with an aminopterin-sensitive mouse myeloma cell line, SP2/0-Ag14, to produce hybridoma cells that secreted a monoclonal antibody (MAb) against AA-II. The selected hybridoma was subsequently cloned by limited dilution method. For MAb, the isotype and an estimated dissociation constant (K(D)) of the MAb were determined. The MAb was used to establish an ELISA method. Accuracy and variation assays, as well as determinations of the specificity and sensitivity, were also carried out and the linear range was 0.19-13 microg/ml. The anti-AA-II MAb showed a very high specificity for AA-II and had low cross-reactivities against the other aristolochic acid (AAs) (CR: AA-I, 3.4%; AA-VIIa, 0.86%) or aristololactam-I (AL-I) (CR<0.07%) except AA-IIIa which has 17% of cross activity. Anti-AA-II MAb also showed negligible cross-reactivity (<0.5%) toward other natural compounds with different chemical structures including barbaloin, sennoside A, rutin, glycyrrhizin, caffeic acid etc. This is the first time that an ELISA method was successfully established for the application of anti-AA-II MAb.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18457371     DOI: 10.1142/S0192415X08005874

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  4 in total

Review 1.  Barbaloin: a concise report of its pharmacological and analytical aspects.

Authors:  D K Patel; K Patel; V Tahilyani
Journal:  Asian Pac J Trop Biomed       Date:  2012-10

Review 2.  Monoclonal Antibodies and Immunoassay for Medical Plant-Derived Natural Products: A Review.

Authors:  Xin Yan; Yan Zhao; Yue Zhang; Huihua Qu
Journal:  Molecules       Date:  2017-02-26       Impact factor: 4.411

Review 3.  Immunological Separation of Bioactive Natural Compounds from Crude Drug Extract and Its Application for Cell-Based Studies.

Authors:  Takuhiro Uto; Tomoe Ohta; Shunsuke Fujii; Yukihiro Shoyama
Journal:  Antibodies (Basel)       Date:  2021-12-06

Review 4.  New Perspectives on Specific Immune-Depletion Technique Using Monoclonal Antibodies against Small Active Molecules in Herbs.

Authors:  Xue-Qian Wang; Fa-Feng Cheng; Hui-Hua Qu; Yan Zhao; Cai Yu; Yuan-Jun Liu; Wen-Xiang Zhu; Qing-Guo Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-17       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.